DEUTSCHE BANK AG\
BankPosition in ACAD — Acadia Pharmaceuticals Inc
CIK 948046
FRANKFURT AM MAIN, 2M
Position in ACAD
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$18,707,614
-$3,424,130 QoQ
Shares Held
840,414
+1.4% QoQ
Ownership
0.491%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.25523135026308463.ToString("F0")%
Shared 0.ToString("F0")%
None 99.74476864973691.ToString("F0")%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DEUTSCHE BANK AG\ holds $2,976,719,496 across 248 Biotechnology names. ACAD ranks #24 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,537,736 | $686,660,626 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
625,388 | $483,199,777 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
761,464 | $251,945,590 | |
| 4 | INCY |
Incyte Corp
|
1,264,195 | $118,986,027 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,453,303 | $117,684,942 | |
| 6 | ARGX |
Argenx SE
|
139,381 | $101,782,972 | |
| 7 | INSM |
INSMED Inc
|
562,474 | $91,975,745 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
306,111 | $61,115,059 |
All Filings in ACAD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $18,707,614 | 840,414 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $22,131,744 | 828,594 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $32,483,747 | 1,522,200 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $15,845,795 | 734,622 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $12,633,464 | 760,594 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $19,128,902 | 1,042,447 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $24,261,257 | 1,577,455 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $20,185,652 | 1,242,194 | Shares | Sole | 2025-06-12 | |
| 2024-03-31 | $19,011,990 | 1,028,231 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $32,106,056 | 1,025,425 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,393,820 | 66,882 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $33,434,343 | 1,396,006 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $8,554,216 | 454,528 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,916,463 | 183,195 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,902,410 | 177,409 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $977,422 | 69,370 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $1,878,769 | 77,571 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,996,922 | 85,558 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $2,806,539 | 168,967 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $3,293,697 | 135,043 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $29,490,147 | 1,143,029 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $55,951,821 | 1,046,611 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $41,997,449 | 1,018,120 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $52,481,132 | 1,082,755 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $54,228,084 | 1,283,505 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||